decaprenoic-acid has been researched along with Obesity* in 1 studies
1 other study(ies) available for decaprenoic-acid and Obesity
Article | Year |
---|---|
Oral Ionic Liquid for Transdermal Delivery and Obesity Treatment.
Obesity is currently a prerequisite for more than 70% of adults, including chronic obesity and long-term obesity. With the increase of diabetes patients in the world, it is urgent to develop effective oral drugs to replace insulin. However, the gastrointestinal tract is a main obstacle to oral drug preparations. Here, a highly effective oral drug was developed, mainly formulated as an ionic liquid (IL) prepared by l-(-)-carnitine and geranic acid. Density functional theory (DFT) calculations showed that l-(-)-carnitine and geranic acid can exist stably through hydrogen bonding. IL can significantly enhance the transdermal transport of drugs. In vitro study of intestinal permeability showed that particles formed by IL can prevent the absorption of intestinal fat. Compared with the control group, oral administration of IL (10 mL kg Topics: Administration, Cutaneous; Blood Glucose; Drug Carriers; Humans; Ionic Liquids; Male; Obesity | 2023 |